<DOC>
	<DOC>NCT01023204</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and the safety of paclitaxel given weekly in patients with advanced or recurrent breast cancer</brief_summary>
	<brief_title>Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Patients with primary advanced inoperable disease who were refractory to chemotherapy Patients with recurrent disease following postoperative adjuvant chemotherapy Patients who were not amenable to postrecurrence chemotherapy Patients with serious, uncontrolled medical illness Patients with previous therapy with taxanes</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>